2005
DOI: 10.1002/med.20043
|View full text |Cite
|
Sign up to set email alerts
|

Eburnamine derivatives and the brain

Abstract: The Apocynaceae plant family contains a great number of so called eburnamine-vincamine alkaloids. Quite a few of these alkaloids exert varied pharmacological activities on the cell multiplication, cardiovascular system, and brain functions. Many derivatives were also synthesized to find pharmacologically active compounds better characterized and safer to be administered than the natural plant alkaloids themselves. We concentrate on the eburnamine structures with cerebral activities in this review. Vincamine, v… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
64
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 100 publications
(66 citation statements)
references
References 69 publications
0
64
0
Order By: Relevance
“…A key element of the secondary cell loss is the increased activity of excitatory amino acid regulated receptors, which elevates [Ca 2+ ] i above the physiological levels and leads to disturbed functions and eventually cell death (De Keyser et al, 1999;Nicholls, 2004;Hazell, 2007). Former clinical and experimental studies in vivo and in vitro have shown that Vinpocetine, developed by Richter Ltd., is able to protect the neurons under ischemic condition by a variety of actions (Bonoczk et al, 2000;Vas and Gulyas, 2005). Vinpocetine can block phosphodiesterase I, which can be important for improvement of cerebral circulation (Pelligrino and Wang, 1998) and can act as an antioxidant .…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…A key element of the secondary cell loss is the increased activity of excitatory amino acid regulated receptors, which elevates [Ca 2+ ] i above the physiological levels and leads to disturbed functions and eventually cell death (De Keyser et al, 1999;Nicholls, 2004;Hazell, 2007). Former clinical and experimental studies in vivo and in vitro have shown that Vinpocetine, developed by Richter Ltd., is able to protect the neurons under ischemic condition by a variety of actions (Bonoczk et al, 2000;Vas and Gulyas, 2005). Vinpocetine can block phosphodiesterase I, which can be important for improvement of cerebral circulation (Pelligrino and Wang, 1998) and can act as an antioxidant .…”
Section: Discussionmentioning
confidence: 99%
“…Importantly, Vinpocetine did not influence the amplitude of the initial glutamate-evoked [Ca 2+ ] i rise indicating that Vinpocetine acts at least partially by influencing mechanisms controlling elevated [Ca 2+ ] i levels. Recent positron emission tomography (PET) studies using radiolabeled PBR ligands and Vinpocetine suggested that mitochondrial peripheral-type benzodiazepine receptors can be therapeutically relevant targets of Vinpocetine Vas and Gulyas, 2005). As mitochondria play an important role in Ca 2+ homeostasis, neuroprotective effects of Vinpocetine can be executed through interfering with PBRs and consequently, via modulating mitochondrial function.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…minor contains eburnamine-type indole alkaloids including vincamine, which has modulatory effects on brain circulation and neuronal homeostasis as well as antihypoxic and neuroprotective potencies (Vas & Gulyas, 2005). However, few studies have been carried out on the cytotoxic activity of the plant extracts (Porska et al, 1988;Sturdikova et al, 1986).…”
Section: Introductionmentioning
confidence: 99%
“…Tetrahydrocarbazole ring can be considered as an isostere to b-carboline ring which is present in many naturally occurring anticancer agents, such as the vinca alkaloids, vincamine (III) and (-)-eburnamonine (IV) (Figure 1) isolated from the Madagascar periwinkle (Catharanthus roseus) [33][34][35] . Although (-)-eburnamonine (IV) was devoid of anticancer activity even at the high dose of 100 M, its synthetic analogue 15-methylene-eburnamonine (V) displayed in vitro micromolar activity against prostate and myeloma cell lines 36 .…”
Section: Introductionmentioning
confidence: 99%